Omrix Biopharmaceuticals, Inc. 4
4 · Omrix Biopharmaceuticals, Inc. · Filed Nov 13, 2006
Insider Transaction Report
Form 4
Mashiach Nissim
Senior V.P., Operations
Transactions
- Exercise/Conversion
Stock Option
2006-11-09−30,000→ 42,728 totalExercise: $2.75Exp: 2010-03-01→ Common Stock (30,000 underlying) - Exercise/Conversion
Stock Option
2006-11-09−12,728→ 0 totalExercise: $16.97Exp: 2007-02-28→ Common Stock (12,728 underlying) - Sale
Common Stock
2006-11-09$22.85/sh−42,728$976,335→ 0 total - Exercise/Conversion
Common Stock
2006-11-09$16.97/sh+12,728$215,994→ 42,728 total - Exercise/Conversion
Common Stock
2006-11-09$2.75/sh+30,000$82,500→ 30,000 total
Footnotes (2)
- [F1]These options vest on an annual basis over a four year period beginning on 02/28/01.
- [F2]These options vest on an annual basis over a four year period beginning on 03/01/03.